Interim efficacy and safety analysis of the regimen containing delamanid in the treatment of multidrug resistant/rifampicin-resistant/extensively drug-resistant tuberculosis: a single-arm, prospective, monocentric, observational study
Abstract Background Multidrug-resistant, rifampicin-resistant, and extensively drug-resistant tuberculosis (MDR-TB/RR-TB/XDR-TB) present significant treatment challenges, requiring effective and safe therapeutic regimens. This study aims to assess the efficacy and safety of a 24-week regimen that in...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2025-12-01
|
| Серія: | BMC Infectious Diseases |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12879-025-11945-9 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|